BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas to sit on a panel titled "Venture Funding" at the EDC BioTech 2008 conference at in Miami, FL
News | 04. 24. 2008
